Featured News

Does living with celiac disease impact your daily life? We need your help to advance celiac disease research and test an investigational medication.  

Is celiac disease holding you back? If so, consider joining the FB102-301 study for people who have celiac disease who are currently on a gluten-free diet. The phase 2 FB102-301 study is researching a potential new…

Is celiac disease having a significant impact on your daily life? You may be eligible for a clinical study. The ASPIRION study is a phase 2 study looking into a new, investigational study drug (amlitelimab) for patients with celiac disease.

New Phase 2 Clinical Trial: TEV-CeD2 Study

Halloween is just around the corner, and this year the Celiac Disease Foundation is proud to partner again with our friends at Food Allergy Research & Education (FARE) to promote the Teal Pumpkin Project, which aims to make this holiday safer for everyone affected by celiac disease, food allergies, intolerances, and other conditions.

What if there was a way to help your immune system become more tolerant of gluten? That’s the potential of VTP-1000, an investigational immunotherapy being studied in the AVALON celiac disease clinical trial.

The Celiac Disease Foundation on May 22 awarded its first Celiac Disease Policy Leadership Award to U.S. Representative Betty McCollum (MN-04) for her distinguished service and advocacy on behalf of the celiac disease patient community. Among other initiatives, she established the bipartisan Congressional Celiac Disease Caucus, which has significantly increased federal recognition of celiac disease.

The future of celiac disease research is promising, with exciting advancements in diagnosis and therapies presented at the 2024 Digestive Disease Week® (DDW) conference in Washington, D.C. Read on for updates the Celiac Disease Foundation team gathered from lectures, posters, and panel discussions at the conference.

On May 20 the Disease Foundation hosted its third annual award reception at Digestive Disease Week in Washington, D.C. From prestigious global research prizes to inaugural student and policy leadership awards, the event spotlighted the extraordinary contributions of individuals dedicated to improving the lives of those affected by celiac disease.

Joining research studies and clinical trials is the only way to help scientists better understand this autoimmune disease and ultimately find a cure for celiac disease. This spring, I joined one of those important trials, funded by the Foundation, to help researchers with the development of a revolutionary new screening tool for celiac disease.